Hanna, Paul
Strohbehn, Ian
Moreno, Daiana
Harden, Destiny
Seethapathy, Harish
Gupta, Shruti
Lee, Meghan
Ouyang, Tianqi
Frigault, Matthew
Sise, Meghan E. http://orcid.org/0000-0002-4327-9713
Funding for this research was provided by:
SG receives research funding from BTG International, GE Healthcare and NIH NIDDK
Potential conflicts of interest include research grant funding from Novartis and Kite, and consulting fees/honorarium from Novartis, Kite, Celgene/BMS, and Arcellx for Dr. Frigault
Article History
Received: 8 June 2022
Revised: 19 July 2022
Accepted: 20 July 2022
First Online: 3 August 2022
Competing interests
: PH, IS, DM, DH, HS, ML, TO, and MES have nothing to declare. MF is a consultant for Novartis, Kite/Gilead, BMS, Iovance, JnJ/Legend, and Arcellx. SG receives research funding from BTG International, GE Healthcare and NIH NIDDK K23DKDK125672.